Setanaxib

GKT137831

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Setanaxib, covering 2024-12-10 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Setanaxib in Patients With Alport Syndrome [Phase 1, Phase 2]